DB
AUXL

Dmitry Balyasny’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Dmitry Balyasny’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-165,000
Closed -$3.31M – 969
2014
Q2 		$3.31M Buy
+165,000
New +$3.78M 0.04% 464
2013
Q3 		– Sell
-167,623
Closed -$2.79M – 809
2013
Q2 		$2.79M Buy
+167,623
New +$2.68M 0.05% 406

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Dmitry Balyasny's AUXL Position: Q3 2014 in Review

Dmitry Balyasny sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 165,000 shares — an estimated $3.31M sold.

Dmitry Balyasny first reported a position in AUXL in Q2 2013 and held it in 2 quarters. The position peaked at $3.31M in Q2 2014. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

  • Dmitry Balyasny reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Dmitry Balyasny sold 165,000 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $3.31M.
  • Dmitry Balyasny first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Dmitry Balyasny's AUXILIUM PHARAMCEUTICALS INC position peaked at $3.31M in Q2 2014.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Balyasny Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.